Dimensional Fund Advisors LP cut its stake in Itron, Inc. (NASDAQ:ITRI - Free Report) by 1.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,255,624 shares of the scientific and technical instruments company's stock after selling 17,351 shares during the period. Dimensional Fund Advisors LP owned approximately 2.78% of Itron worth $136,339,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also made changes to their positions in ITRI. First Trust Advisors LP boosted its holdings in shares of Itron by 9.1% during the fourth quarter. First Trust Advisors LP now owns 802,584 shares of the scientific and technical instruments company's stock worth $87,145,000 after purchasing an additional 66,637 shares during the last quarter. Norges Bank acquired a new position in Itron during the 4th quarter worth approximately $64,615,000. Vontobel Holding Ltd. boosted its stake in shares of Itron by 8.1% in the fourth quarter. Vontobel Holding Ltd. now owns 464,787 shares of the scientific and technical instruments company's stock valued at $50,467,000 after purchasing an additional 34,842 shares during the period. Arrowstreet Capital Limited Partnership lifted its holdings in Itron by 85.7% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 425,484 shares of the scientific and technical instruments company's stock worth $46,199,000 after buying an additional 196,396 shares in the last quarter. Finally, Renaissance Technologies LLC increased its holdings in Itron by 3.1% during the 4th quarter. Renaissance Technologies LLC now owns 350,461 shares of the scientific and technical instruments company's stock worth $38,053,000 after purchasing an additional 10,400 shares during the last quarter. Institutional investors and hedge funds own 96.19% of the company's stock.
Insider Buying and Selling
In related news, SVP Christopher E. Ware sold 648 shares of the stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $92.90, for a total value of $60,199.20. Following the completion of the sale, the senior vice president now directly owns 20,326 shares of the company's stock, valued at approximately $1,888,285.40. This represents a 3.09 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Mary C. Hemmingsen sold 750 shares of the business's stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $107.27, for a total transaction of $80,452.50. Following the transaction, the director now owns 5,630 shares in the company, valued at approximately $603,930.10. This represents a 11.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 4,037 shares of company stock valued at $385,815. 1.45% of the stock is owned by corporate insiders.
Wall Street Analysts Forecast Growth
A number of research firms have recently weighed in on ITRI. Piper Sandler raised their price target on shares of Itron from $119.00 to $124.00 and gave the stock a "neutral" rating in a research report on Thursday, February 27th. StockNews.com lowered Itron from a "strong-buy" rating to a "buy" rating in a report on Saturday, March 1st. Oppenheimer boosted their price target on Itron from $124.00 to $131.00 and gave the company an "outperform" rating in a report on Wednesday, February 26th. Guggenheim reissued a "buy" rating and set a $133.00 target price on shares of Itron in a report on Thursday, April 17th. Finally, Canaccord Genuity Group boosted their price objective on shares of Itron from $130.00 to $132.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Three analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to data from MarketBeat.com, Itron has an average rating of "Moderate Buy" and a consensus price target of $127.64.
Get Our Latest Stock Report on ITRI
Itron Price Performance
Shares of NASDAQ ITRI traded up $0.56 during trading on Wednesday, hitting $111.44. The company had a trading volume of 350,134 shares, compared to its average volume of 572,977. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.83 and a current ratio of 3.36. The company has a market cap of $5.08 billion, a P/E ratio of 22.84, a PEG ratio of 0.81 and a beta of 1.39. The business's 50-day moving average is $103.59 and its 200 day moving average is $107.47. Itron, Inc. has a 52 week low of $90.03 and a 52 week high of $124.90.
Itron Company Profile
(
Free Report)
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
Featured Stories

Before you consider Itron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.
While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Like this article? Share it with a colleague.
Link copied to clipboard.